Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis
about
Isolation of protein-tyrosine phosphatase-like member-a variant from cementumELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesisIdentification of residues important for the catalysis, structure maintenance, and substrate specificity of yeast 3-hydroxyacyl-CoA dehydratase Phs1.Mouse aldehyde dehydrogenase ALDH3B2 is localized to lipid droplets via two C-terminal tryptophan residues and lipid modificationTwo modes of regulation of the fatty acid elongase ELOVL6 by the 3-ketoacyl-CoA reductase KAR in the fatty acid elongation cycleMetabolism of very long-chain Fatty acids: genes and pathophysiology.Centronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide.Genetics of kidney disease and related cardiometabolic phenotypes in Zuni Indians: the Zuni Kidney Project.The role of fatty acid elongation in epidermal structure and function.Monocyte to macrophage differentiation goes along with modulation of the plasmalogen pattern through transcriptional regulation.Phs1 and the synthesis of very long chain Fatty acids are required for ballistospore formation.HACD1, a regulator of membrane composition and fluidity, promotes myoblast fusion and skeletal muscle growth.Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray.Congenital myopathy is caused by mutation of HACD1.Mutation for nonsyndromic mental retardation in the trans-2-enoyl-CoA reductase TER gene involved in fatty acid elongation impairs the enzyme activity and stability, leading to change in sphingolipid profileEndoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.The 3-hydroxyacyl-CoA dehydratases HACD1 and HACD2 exhibit functional redundancy and are active in a wide range of fatty acid elongation pathways.PTPLAD2 is a tumor suppressor in esophageal squamous cell carcinogenesis.Enzyme Activities of the Ceramide Synthases CERS2-6 Are Regulated by Phosphorylation in the C-terminal Region.Genomewide approaches for BACH1 target genes in mouse embryonic fibroblasts showed BACH1-Pparg pathway in adipogenesis.De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.Hetero-oligomeric interactions of an ELOVL4 mutant protein: implications in the molecular mechanism of Stargardt-3 macular dystrophy.Phytosphingosine degradation pathway includes fatty acid α-oxidation reactions in the endoplasmic reticulum.PTPLs dehydrate VLC3HA-CoA to VLCTDA-CoABiochemical characterization of the very long-chain fatty acid elongase ELOVL7.
P2860
10b86f2bd662dcd91616da5afb45239b3300708e25d216ba065107c2d71583a6d4e4896d8ac012ab299643adc838775c26cc4a3f1f2dd45bc0275dea48779d4014665fabbfef1fc446a7957ef960ee724ccbc1c71eeaa2fe6749561a4d76f29174ac570e613ae5d2abd452e92bb10225953974a89d06cc5978f42a540d1431dd03cdc986a85861bc8666102688cae09a05b983341833960f009e5a57febdd98b9efc22c2d9f19e729a5df46785a834a5d1656638c860b25243fa67e54fb389f34dc3f567ccbc8bb1faff12894658c85ecc2c2c5e2c87d3fce8f344aafc3558c2fc250d97f7514ac73e0de75f140f16ed
P248
Q24296472-875F063B-95C7-4293-822C-51E77A1820C0Q24302388-8D4E75AD-9490-446A-B5BE-BB2193DA29B1Q27939483-248C84EF-01CC-470E-BAEC-6AC71F328623Q28115553-D70E2FDA-F499-480F-95C4-A47B46843470Q28540503-47B3F6CF-D164-4E60-ACCE-7EC9EF5C3738Q34416437-0DDAF12E-13E0-4A3D-A3E0-F34531919029Q34447103-4827A8AB-FD23-4A31-91DF-320A0412DB4AQ35031001-07E18868-F5E5-4E07-92CE-67EC887A28E4Q35050713-6AA6B5E4-CE64-471B-8952-A692B1A95E62Q35143143-498A7353-14CE-4AF8-A941-C9A96DFD0216Q35229818-BCBB84FA-8ECF-477A-A161-3207B54A9321Q36110170-CFC9E9F1-934A-4EDF-BB83-14AAB971B73FQ36802641-4A2F879E-4007-441F-A6B1-89C88DF1ABCDQ37346978-1545D7D0-534B-489D-9D2D-974057EA6B6AQ37405081-4F2586AF-2691-4C70-AD71-FF3FAE07DBD8Q37665462-7EB4B448-7DAA-4328-8B3F-3D839A37FB53Q38627275-4E15275A-404F-4358-B05B-598E479DBAFCQ38695571-D1335180-25E9-4145-8453-8DDB1B0A2C91Q39023580-2CB9D373-E238-4C3D-B070-E78164A08A70Q39770462-3997F9B7-53C4-4327-A03E-C4B2015F301EQ39876234-317CA504-D521-4C13-A4EB-09F989864A34Q40630509-FD9B71A4-5BA1-4214-9FDB-2D6B1E9981FFQ41234344-F987B1A4-52DB-4E0A-B063-5241BBF54237Q41677978-BDE0E411-DDBD-450F-8B9D-827AA2524EFAQ50293480-EB673450-684E-4356-9416-EB0276F64C65Q50335979-74607A9A-2A66-4A54-B2B4-58843044B4C5
P2860
Characterization of four mammalian 3-hydroxyacyl-CoA dehydratases involved in very long-chain fatty acid synthesis
description
2008 nî lūn-bûn
@nan
2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Characterization of four mamma ...... ong-chain fatty acid synthesis
@ast
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en-gb
Characterization of four mamma ...... ong-chain fatty acid synthesis
@nl
type
label
Characterization of four mamma ...... ong-chain fatty acid synthesis
@ast
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en-gb
Characterization of four mamma ...... ong-chain fatty acid synthesis
@nl
prefLabel
Characterization of four mamma ...... ong-chain fatty acid synthesis
@ast
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en-gb
Characterization of four mamma ...... ong-chain fatty acid synthesis
@nl
P2093
P2860
P921
P1433
P1476
Characterization of four mamma ...... ong-chain fatty acid synthesis
@en
P2093
Hiroko Sakuraba
Masao Yamanaka
Mika Ikeda
Yasuyuki Igarashi
Yuki Kanao
Yukiko Mizutani
P2860
P304
P356
10.1016/J.FEBSLET.2008.06.007
P407
P50
P577
2008-07-09T00:00:00Z